US 8513244
Neprilysin inhibitors
granted A61KA61K31/415A61K31/4155
Quick answer
US patent 8513244 (Neprilysin inhibitors) held by Theravance, Inc. expires Mon Aug 15 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Theravance, Inc.
- Grant date
- Tue Aug 20 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 15 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K31/415, A61K31/4155, A61K31/4178, A61K31/422